• Exchange: Munich
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

OC5:GR

43.691 EUR 0.039 0.09%

As of 11:20:13 ET on 07/30/2014.

Snapshot for Cochlear Ltd (OC5)

Open: 44.225 Day's Range: 43.506 - 44.225 Volume: 668
Previous Close: 43.730 52wk Range: 34.980 - 44.769 1-Yr Rtn: +8.87%

Stock Chart for OC5

No chart data available.
  • OC5:GR 43.691
  • 1D
  • 1M
  • 1Y
43.730
Interactive OC5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OC5

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 34.5671
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) 1.8150
Est. PEG Ratio 7.3814
Market Cap (M EUR) 2,493.10
Shares Outstanding (M) 57.06
30 Day Average Volume 78
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.09%
Cash Dividend (AUD) 1.2700
Dividend Ex-Date 02/28/2014
5 Year Dividend Growth 13.97%
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OC5

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for OC5

Cochlear Limited researches, develops and markets cochlear implant systems for hearing impaired individuals. The Company's hearing implant systems include Nucleus and Baha and are sold both domestically and internationally.

Christopher Graham Roberts "Chris"President/CEORichard BrookPres:European
Mark D SalmonPres:Asia PacificNeville J MitchellCFO/Secretary
More Company Profile & Key Executives for OC5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil